Pietro Andreoné

21.0k total citations · 2 hit papers
346 papers, 9.9k citations indexed

About

Pietro Andreoné is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Pietro Andreoné has authored 346 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 273 papers in Hepatology, 228 papers in Epidemiology and 45 papers in Surgery. Recurrent topics in Pietro Andreoné's work include Hepatitis C virus research (192 papers), Liver Disease Diagnosis and Treatment (163 papers) and Hepatitis B Virus Studies (119 papers). Pietro Andreoné is often cited by papers focused on Hepatitis C virus research (192 papers), Liver Disease Diagnosis and Treatment (163 papers) and Hepatitis B Virus Studies (119 papers). Pietro Andreoné collaborates with scholars based in Italy, United States and Germany. Pietro Andreoné's co-authors include Mauro Bernardi, Carmela Cursaro, Antonio Craxı̀, Elisabetta Loggi, Calogero Cammà, Annagiulia Gramenzi, Stefano Gitto, Fabio Conti, G. Mazzella and Franco Trevisani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Pietro Andreoné

331 papers receiving 9.6k citations

Hit Papers

Early occurrence and recu... 2002 2026 2010 2018 2016 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
    2016 653 citations Fabio Conti, F. Buonfiglioli et al. profile →
  2. Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
    2002 650 citations Pietro Andreoné et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pietro Andreoné 7.7k 7.1k 1.3k 824 822 346 9.9k
Massimo Colombo 9.6k 1.3× 8.5k 1.2× 1.0k 0.8× 563 0.7× 787 1.0× 201 11.8k
Eiji Tanaka 7.9k 1.0× 7.7k 1.1× 1.7k 1.4× 595 0.7× 837 1.0× 280 11.2k
Wan‐Long Chuang 8.5k 1.1× 8.3k 1.2× 732 0.6× 733 0.9× 525 0.6× 513 11.1k
Fumitaka Suzuki 9.6k 1.3× 9.1k 1.3× 866 0.7× 1.1k 1.4× 612 0.7× 404 11.5k
Marion G. Peters 7.0k 0.9× 7.0k 1.0× 1.0k 0.8× 1.4k 1.7× 526 0.6× 211 9.9k
Jenny Heathcote 10.0k 1.3× 9.9k 1.4× 1.7k 1.3× 843 1.0× 776 0.9× 175 12.6k
Yasuji Arase 9.1k 1.2× 8.7k 1.2× 726 0.6× 873 1.1× 532 0.6× 394 11.6k
John M. Vierling 7.1k 0.9× 5.9k 0.8× 1.9k 1.5× 891 1.1× 502 0.6× 213 8.7k
Mario Rizzetto 8.4k 1.1× 10.8k 1.5× 1.3k 1.0× 1.0k 1.2× 348 0.4× 308 13.0k
Young‐Suk Lim 8.5k 1.1× 6.9k 1.0× 1.9k 1.5× 507 0.6× 1.4k 1.6× 336 11.0k

Countries citing papers authored by Pietro Andreoné

Since Specialization
Citations

This map shows the geographic impact of Pietro Andreoné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Andreoné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Andreoné more than expected).

Fields of papers citing papers by Pietro Andreoné

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Andreoné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Andreoné. The network helps show where Pietro Andreoné may publish in the future.

Co-authorship network of co-authors of Pietro Andreoné

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Andreoné. A scholar is included among the top collaborators of Pietro Andreoné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Andreoné. Pietro Andreoné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gabrielli, Filippo, et al.. (2024). Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments. Biomolecules. 14(10). 1227–1227. 3 indexed citations
2.
Gabrielli, Filippo, et al.. (2024). Metabolic Disorders in Liver Transplant Recipients: The State of the Art. Journal of Clinical Medicine. 13(4). 1014–1014. 9 indexed citations
3.
Agostino, Stefania, Carmela Cursaro, Cristina Felicani, et al.. (2023). Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series. Biomedicines. 11(10). 2848–2848. 5 indexed citations
4.
5.
Gabrielli, Filippo, et al.. (2021). Treatments for HBV: A Glimpse into the Future. Viruses. 13(9). 1767–1767. 10 indexed citations
6.
Mazzaro, Cesare, Luigino Dal Maso, Marcella Visentini, et al.. (2021). Hepatitis C virus‐associated indolent B‐cell lymphomas: A review on the role of the new direct antiviral agents therapy. Hematological Oncology. 39(4). 439–447. 3 indexed citations
7.
8.
Mazzaro, Cesare, Luigino Dal Maso, Marcella Visentini, et al.. (2019). Hepatitis B virus‐related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review. Journal of Internal Medicine. 286(3). 290–298. 17 indexed citations
9.
Pettinari, Irene, Ranka Vukotic, Horia Ştefănescu, et al.. (2018). Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis. The American Journal of Gastroenterology. 114(2). 258–266. 80 indexed citations
10.
Casadei‐Gardini, Andrea, Francesco Giuseppe Foschi, Fabio Conti, et al.. (2018). Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Digestive and Liver Disease. 51(5). 681–688. 47 indexed citations
11.
Agarwal, Kosh, Sang Hoon Ahn, Audrey Lau, et al.. (2018). Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment. Journal of Viral Hepatitis. 25(11). 1331–1340. 71 indexed citations
12.
Ravaioli, Federico, Fabio Conti, S. Brillanti, et al.. (2018). Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals. Digestive and Liver Disease. 50(6). 573–579. 52 indexed citations
13.
Renzulli, Matteo, F. Buonfiglioli, Fabio Conti, et al.. (2017). Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis. European Radiology. 28(2). 506–513. 62 indexed citations
14.
Gitto, Stefano, et al.. (2016). Efficacy and Safety of Daclatasvir in Hepatitis C: An Overview. Journal of Clinical and Translational Hepatology. 4(4). 336–344. 12 indexed citations
15.
Fiorino, Sirio, Elisabetta Loggi, Gabriella Verucchi, et al.. (2016). Vitamin E for the treatment of E‐antigen‐positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. Liver International. 37(1). 54–61. 6 indexed citations
16.
Niro, Grazia Anna, Antonina Smedile, Rosanna Fontana, et al.. (2016). HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response. Alimentary Pharmacology & Therapeutics. 44(6). 620–628. 40 indexed citations
17.
Gitto, Stefano, Giovanni Vitale, Erica Villa, & Pietro Andreoné. (2014). Update on Alcohol and Viral Hepatitis. Journal of Clinical and Translational Hepatology. 2(4). 228–33. 17 indexed citations
18.
Berg, Thomas, Pietro Andreoné, Stanislas Pol, et al.. (2014). Low‐density lipoprotein and other predictors of response with telaprevir‐based therapy in treatment‐experienced HCV genotype 1 patients: REALIZE study. Liver International. 35(2). 448–454. 5 indexed citations
19.
Bagaglio, Sabrina, Raffaele Bruno, S. Lodrini, et al.. (2004). Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.. PubMed. 17(2). 153–61. 9 indexed citations
20.
Andreoné, Pietro, et al.. (1995). Hepatitis C virus infection and lymphoproliferative disorders.. Blood. 86(9). 3610–1. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Colombo Breakdown of academic impact, for papers by Eiji Tanaka Breakdown of academic impact, for papers by Wan‐Long Chuang Breakdown of academic impact, for papers by Fumitaka Suzuki Breakdown of academic impact, for papers by Marion G. Peters Breakdown of academic impact, for papers by Jenny Heathcote Breakdown of academic impact, for papers by Yasuji Arase Breakdown of academic impact, for papers by John M. Vierling Breakdown of academic impact, for papers by Mario Rizzetto Breakdown of academic impact, for papers by Young‐Suk Lim
Rankless by CCL
2026